A broad-spectrum human lung fibroblast-derived mitogen is a variant of hepatocyte growth factor.

Jeffrey S. Rubin(National Cancer Institute), Andrew M. Chan(National Cancer Institute), Donald P. Bottaro(National Cancer Institute), W H Burgess(National Cancer Institute), W Taylor(National Cancer Institute), ALEX C. CECH(National Cancer Institute), David W. Hirschfield(National Cancer Institute), Joel Wong(National Cancer Institute), T Miki(National Cancer Institute), Paul W. Finch(National Cancer Institute)
Proceedings of the National Academy of Sciences
January 15, 1991
Cited by 501Open Access

Abstract

A heparin-binding mitogen was isolated from conditioned medium of human embryonic lung fibroblasts. It exhibited broad target-cell specificity whose pattern was distinct from that of any known growth factor. It rapidly stimulated tyrosine phosphorylation of a 145-kDa protein in responsive cells, suggesting that its signaling pathways involved activation of a tyrosine kinase. Purification identified a major polypeptide with an apparent molecular mass of 87 kDa under reducing conditions. Partial amino acid sequence analysis and cDNA cloning revealed that it was a variant of hepatocyte growth factor, a mitogen thought to be specific for hepatic cells and structurally related to plasminogen. Recombinant expression of the cDNA in COS-1 cells established that it encoded the purified growth factor. Its site of synthesis and spectrum of targets imply that this growth factor may play an important role as a paracrine mediator of the proliferation of melanocytes and endothelial cells, as well as cells of epithelial origin.


Related Papers

No related papers found

Powered by citation graph analysis